Hymecromone

Chemical formula: C₁₀H₈O₃  Molecular mass: 176.169 g/mol  PubChem compound: 5280567

Active ingredient description

Hymecromone is an inhibitor of hyaluronic acid synthesis and has a spasmolytic effect on extrahepatic bile ducts. Hymecromone is an approved prescription drug used for treating biliary spasm. This action takes place through a musculotropic mechanism, without atropinic effects. Increased choleresis is also observed without excitation of gall bladder contraction.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A05AX02 Hymecromone A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AX Other drugs for bile therapy
Discover more medicines within A05AX02

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 90-33-5
DrugBank Drug: DB07118
PubChem Compound: 5280567
RxNorm Ingredient: 5556
SNOMED-CT Concept: 769089007
Hymecromone (substance)
UNII Identifier: 3T5NG4Q468
HYMECROMONE

Medicines

Hymecromone is an active ingredient of these brands:

France (FR)

Lithuania (LT)

Poland (PL)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.